SEC Filings
ADAR1's Private Funds Hold 5.2% Of Aura Biosciences' Common Shares
The investment adviser and its sole manager reported the same fund-held position and certified that it was held without a control purpose.
Aura Biosciences (AURA) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
SEC Filings
The investment adviser and its sole manager reported the same fund-held position and certified that it was held without a control purpose.
SEC Filings
Treatment is complete for all 108 late-stage trial participants, and Aura expects its funding to last into the first half of 2029.
SEC Filings
The asset manager's business units hold 5,219,492 shares of the eye-cancer drug developer as of September 30.